IP Library › Granted Patent US 11,229,374
Granted Patent B2
US 11,229,374 · App. 16/126,523 · Granted Jan 25, 2022

Plethysmograph variability processor

Inventors: Ammar Al-Ali (San Juan Capistrano, CA); Walter M. Weber (Laguna Hills, CA); Anmol B. Majmudar (Irvine, CA)
Assignee: Masimo Corporation
A61B5/0295A61B5/0261A61B5/02416A61B5/14551A61B5/4848A61B5/7278G16H50/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,229,374
App. No.
16/126,523
Granted
Jan 25, 2022
Kind
B2
Abstract

A plethysmograph variability processor inputs a plethysmograph waveform having pulses corresponding to pulsatile blood flow within a tissue site. The processor derives plethysmograph values based upon selected plethysmograph features, determines variability values, and calculates a plethysmograph variability parameter. The variability values indicate the variability of the plethysmograph features. The plethysmograph variability parameter is representative of the variability values and provides a useful indication of various physiological conditions and the efficacy of treatment for those conditions.

Claims (45)

1. A method of determining an efficacy of a treatment that includes administering a substance to a patient, the method comprising:

receiving a data signal from a physiological sensor during the treatment;

generating a plethysmograph waveform based at least in part on the data signal, wherein the plethysmograph waveform comprises a plurality of pulses corresponding to pulsatile blood flow within tissue of the patient;

determining a first plurality of perfusion parameters, wherein each perfusion parameter of the first plurality of perfusion parameters is determined based at least in part on a peak amplitude and a valley amplitude of a corresponding pulse of the plurality of pulses;

determining a first measure of variability of the first plurality of perfusion parameters based at least in part on a difference between a first and second perfusion parameter of the first plurality of perfusion parameters relative to the first perfusion parameter of the first plurality of perfusion parameters;

comparing the first measure of variability of the first plurality of perfusion parameters with one or more second measures of variability of a second plurality of perfusion parameters to identify a variability trend; and

based at least in part on the variability trend, causing a display device to display an indication of the efficacy of the treatment.

2. The method of claim 1 , wherein the substance comprises a drug.

3. The method of claim 1 , wherein the indication of the efficacy of the treatment comprises an indication of an efficacy of administration of the substance to the patient.

4. The method of claim 1 , wherein the plurality of pulses is a first plurality of pulses, wherein the plethysmograph waveform further comprises a second plurality of pulses corresponding to the pulsatile blood flow within the tissue of the patient, the method further comprising:

determining the second plurality of perfusion parameters, wherein each perfusion parameter of the second plurality of perfusion parameters is determined based at least in part on a peak amplitude and a valley amplitude of a corresponding pulse of the second plurality of pulses; and

determining the one or more second measures of variability of the second plurality of perfusion parameters based at least in part on a difference between a first and second perfusion parameter of the second plurality of perfusion parameters relative to the first perfusion parameter of the second plurality of perfusion parameters.

5. The method of claim 1 , wherein said determining the first plurality of perfusion parameters is based at least in part on a difference between the peak amplitude and the valley amplitude of a corresponding pulse of the plurality of pulses relative to the peak amplitude.

6. The method of claim 1 , wherein said determining the first measure of variability of the first plurality of perfusion parameters comprises:

sorting a series of the first plurality of perfusion parameters based on size; and

removing at least two perfusion parameters from the series of the first plurality of perfusion parameters to form a modified series of perfusion parameters, wherein the modified series of perfusion parameters comprises the first and second perfusion parameters.

7. The method of claim 6 , wherein said removing the at least two perfusion parameters from the series of the first plurality of perfusion parameters comprises:

removing at least one perfusion parameter from a set of largest perfusion parameters of the series; and

removing at least one perfusion parameter from a set of smallest perfusion parameters of the series.

8. The method of claim 1 , wherein each of the first plurality of perfusion parameters correspond to a perfusion index.

9. The method of claim 1 , wherein the first measure of variability of the first plurality of perfusion parameters corresponds to a Pleth variability index.

10. The method of claim 1 , wherein the treatment is a treatment for asthma.

11. A patient monitor configured to determine an efficacy of a treatment that includes administering a substance to a patient, the patient monitor comprising:

one or more processors configured to:

receive a data signal from a physiological sensor during the treatment;

generate a plethysmograph waveform based at least in part on the data signal, wherein the plethysmograph waveform comprises a plurality of pulses corresponding to pulsatile blood flow within tissue of the patient;

determine a first plurality of perfusion parameters, wherein each perfusion parameter of the first plurality of perfusion parameters is determined based at least in part on a peak amplitude and a valley amplitude of a corresponding pulse of the plurality of pulses;

determine a first measure of variability of the first plurality of perfusion parameters based at least in part on a difference between a first and second perfusion parameter of the first plurality of perfusion parameters relative to the first perfusion parameter of the first plurality of perfusion parameters;

compare the first measure of variability of the first plurality of perfusion parameters with one or more second measures of variability of a second plurality of perfusion parameters to identify a variability trend; and

based at least in part on the variability trend, cause a display device to display an indication of the efficacy of the treatment.

12. The patient monitor of claim 11 , wherein the substance comprises a drug.

13. The patient monitor of claim 11 , wherein the indication of the efficacy of the treatment comprises an indication of an efficacy of administration of the substance to the patient.

14. The patient monitor of claim 11 , wherein the plurality of pulses is a first plurality of pulses, wherein the plethysmograph waveform further comprises a second plurality of pulses corresponding to the pulsatile blood flow within the tissue of the patient, wherein the one or more processors are further configured to:

determine the second plurality of perfusion parameters, wherein each perfusion parameter of the second plurality of perfusion parameters is determined based at least in part on a peak amplitude and a valley amplitude of a corresponding pulse of the second plurality of pulses; and

determine the one or more second measures of variability of the second plurality of perfusion parameters based at least in part on a difference between a first and second perfusion parameter of the second plurality of perfusion parameters relative to the first perfusion parameter of the second plurality of perfusion parameters.

15. The patient monitor of claim 11 , wherein to determine the first plurality of perfusion parameters, the one or more processors are further configured to determine the first plurality of perfusion parameters based at least in part on a difference between the peak amplitude and the valley amplitude of a corresponding pulse of the plurality of pulses relative to the peak amplitude.

16. The patient monitor of claim 11 , wherein to determine the first measure of variability of the first plurality of perfusion parameters, the one or more processors are further configured to:

sort a series of the first plurality of perfusion parameters based on size; and

remove at least two perfusion parameters from the series of the first plurality of perfusion parameters to form a modified series of perfusion parameters, wherein the modified series of perfusion parameters comprises the first and second perfusion parameters.

17. The patient monitor of claim 16 , wherein to remove the at least two perfusion parameters from the series of the first plurality of perfusion parameters, the one or more processors are further configured to:

remove at least one perfusion parameter from a set of largest perfusion parameters of the series; and

remove at least one perfusion parameter from a set of smallest perfusion parameters of the series.

18. The patient monitor of claim 11 , wherein each of the first plurality of perfusion parameters correspond to a perfusion index.

19. The patient monitor of claim 11 , wherein the first measure of variability of the first plurality of perfusion parameters corresponds to a Pleth variability index.

20. The patient monitor of claim 11 , wherein the treatment is a treatment for asthma.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2024
From: AL-ALI, AMMAR; WEBER, WALTER; MAJMUDAR, ANMOL
To: MASIMO CORPORATION
Reel/Frame 068024/0398 →
Cited By (1)
US 12,329,548